Mushroom supplement may slow prostate cancer progression, City of Hope study finds

Advancing peritoneal oncology: Innovations in surgical strategies and research

Peritoneal metastases arise from gastrointestinal and gynecologic malignancies, leading to debilitating symptoms and poor prognoses. They remain one of the most challenging manifestations of advanced malignancies, often leading to significant morbidity and limited treatment options.

HHS said it would terminate Women’s Health Initiative, then reconsidered

On April 21, Women’s Health Initiative investigators were informed that HHS would be terminating the WHI Regional Center contracts at the end of the current fiscal year.

April 25, 2025

Vol.51 No.16

By Jacquelyn Cobb and Claire Marie Porter

In Brief

Swim Across America grants $900,000 toward gene editing innovation

Joseph FraiettaPietro GenoveseSwim Across America, the nonprofit funding innovative clinical trials and patient-centered programs for cancer, awarded $450,000 grants to two of its beneficiaries, Alliance for Cancer Gene Therapy and Dana-Farber Cancer Institute, to support the work of novel gene and base editing techniques used in advanced cancer research, including targeted therapies, immunotherapies, and cellular therapies.

April 25, 2025

Vol.51 No.16

Clinical Roundup

Cleveland Clinic Abu Dhabi performs first-ever transcontinental robotic assisted focal therapy procedure for prostate cancer

Cleveland Clinic Abu Dhabi, in collaboration with experts from Cleveland Clinic in the U.S., performed the world’s first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer.

April 25, 2025

Vol.51 No.16

City of Hope’s BMT program performs 20,000th transplant
49-year history creates 20,000 tomorrows

This year marks the 49th anniversary of the City of Hope bone marrow transplant program, which was conceived and developed by Ernest Beutler and Karl Blume in 1975, with help and inspiration from E. Donnall Thomas, the 1990 Nobel Laureate in Physiology and Medicine.

Hope Rugo named director of City of Hope’s Women’s Cancers Program

Hope S. Rugo has joined City of Hope to lead its Women’s Cancers Program throughout the organization and breast medical oncology division section.

April 18, 2025

Vol.51 No.15

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

YOU MAY BE INTERESTED IN

Advancing peritoneal oncology: Innovations in surgical strategies and research

HHS said it would terminate Women’s Health Initiative, then reconsidered

Swim Across America grants $900,000 toward gene editing innovation

Cleveland Clinic Abu Dhabi performs first-ever transcontinental robotic assisted focal therapy procedure for prostate cancer

City of Hope’s BMT program performs 20,000th transplant
49-year history creates 20,000 tomorrows

Hope Rugo named director of City of Hope’s Women’s Cancers Program

Renew today!

Subscriber content

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

YOU MAY BE INTERESTED IN

Advancing peritoneal oncology: Innovations in surgical strategies and research

HHS said it would terminate Women’s Health Initiative, then reconsidered

Swim Across America grants $900,000 toward gene editing innovation

Cleveland Clinic Abu Dhabi performs first-ever transcontinental robotic assisted focal therapy procedure for prostate cancer

City of Hope’s BMT program performs 20,000th transplant49-year history creates 20,000 tomorrows

Hope Rugo named director of City of Hope’s Women’s Cancers Program

City of Hope’s BMT program performs 20,000th transplant
49-year history creates 20,000 tomorrows